Vaidya Sane Ayurved Laboratories Ltd operating margin is expanding. Margin expansion is usually a good sign.
The historical rank and industry rank for Vaidyane Ayurved Laboratories's Operating Margin % or its related term are showing as below:
NSE:MADHAVBAUG'
s Operating Margin % Range Over the Past 10 Years
Min: 0.91 Med: 4.95 Max: 11.31
Current: 8.69
NSE:MADHAVBAUG's Operating Margin % is ranked better than 52.84% of 952
companies
in the Drug Manufacturers industry
Industry Median: 7.58
vs NSE:MADHAVBAUG: 8.69
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Vaidyane Ayurved Laboratories Operating Margin % Related Terms
Vaidyane Ayurved Laboratories Operating Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:MADHAVBAUG vs ZTS, UTHR: Operating Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Vaidyane Ayurved Laboratories's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vaidyane Ayurved Laboratories Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vaidyane Ayurved Laboratories's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Vaidyane Ayurved Laboratories's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) has a Operating Margin % of 6.44% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Vaidyane Ayurved Laboratories and its competitors. This is 30% above median its historical median of 4.95. Over the past decade, Vaidyane Ayurved Laboratories' Operating Margin % has ranged from 0.91 to 11.31. According to the industry distribution chart, Vaidyane Ayurved Laboratories ranks #449 out of 952 companies in the Drug Manufacturers industry, placing it in the top 47.2%.
Is Vaidyane Ayurved Laboratories' Operating Margin % too high?
Vaidyane Ayurved Laboratories' current Operating Margin % of 6.44% is 30% above median its 10-year median of 4.95. Over the past 10 years, this metric has ranged from a low of 0.91 to a high of 11.31. The Drug Manufacturers industry median Operating Margin % is 7.58. Vaidyane Ayurved Laboratories' value of 6.44% is 15% below this industry median. Based on the distribution chart, Vaidyane Ayurved Laboratories ranks #449 out of 952 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Vaidyane Ayurved Laboratories has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vaidyane Ayurved Laboratories' Operating Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vaidyane Ayurved Laboratories ranks #449 out of 952 companies for Operating Margin %. This puts Vaidyane Ayurved Laboratories in the upper half of its industry. The industry median Operating Margin % is 7.58. Vaidyane Ayurved Laboratories' value of 6.44% is 15% below this benchmark. Historically, Vaidyane Ayurved Laboratories' own Operating Margin % has ranged from 0.91 to 11.31 over the past decade. While the company's 10-year median is 4.95 vs. the industry median of 7.58, Vaidyane Ayurved Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.58, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vaidyane Ayurved Laboratories's current Operating Margin % of 6.44% is 15% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Vaidyane Ayurved Laboratories and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vaidyane Ayurved Laboratories's current Operating Margin % is 6.44%, which is 30% above median its own 10-year median of 4.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaidyane Ayurved Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹216.94, compared to a current price of ₹180.60 — trading 16.8% below its estimated fair value. The current Operating Margin % is 6.44%, which is 30% above median its 10-year median of 4.95 and 15% below the Drug Manufacturers industry median of 7.58. Vaidyane Ayurved Laboratories' overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG), the current Operating Margin % is 6.44% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Overvalued in 2026?
Based on GuruFocus' analysis, Vaidyane Ayurved Laboratories stock appears to be undervalued.
The current stock price of ₹180.60 is trading 16.8% below its estimated GF Value™ of ₹216.94.
GuruFocus considers Vaidyane Ayurved Laboratories to be Modestly Undervalued.
Key valuation signals for NSE:MADHAVBAUG:
Operating Margin %: 6.44% (30% above median its 10-year median of 4.95)
GF Value™: ₹216.94 vs. price of ₹180.60 (16.8% below fair value)
Industry Position: 15% below the Drug Manufacturers median (#449 of 952)
No single metric tells the full story. See the NSE:MADHAVBAUG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vaidyane Ayurved Laboratories Business Description
Vaidya Sane Ayurved Laboratories Ltd is a medical service institution. The company engaged in research and development in Ayurvedic Medicines and the sale of Ayurvedic medicines & products through its various franchises and own clinics. The Company is also engaged in providing Ayurved medical professional services across its various clinics, including panchkarma and other Ayurvedic treatments through the running of an Ayurvedic Hospital. The company mainly offers treatment for health disease reversal, diabetes reversal, BP management, obesity management, and knee pain relief. The company's business is divided into three segments, i.e., Hospital Activity, Sale of Product, and Common. It derives maximum revenue from the sale of Products.
81GF Score
Get the complete analysis for NSE:MADHAVBAUG
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MADHAVBAUG has been successfully added to your 
